⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Pomerantz LLP Calls Attention to Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics Ready to Announce with Confidence?
newsfilecorp.com
VTGN
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
VTGN
VTGN Stockholders Have Opportunity to Lead Vistagen Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
VTGN
Pomerantz LLP Calls Attention to Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN
prnewswire.com
VTGN
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
VTGN
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Alerts Shareholders to Investor Suit Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
KLAR SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Klarna (KLAR) Investors of Securities Class Action Deadline on February 20, 2026 Ready to Announce with Confidence?
newsfilecorp.com
KLAR
BYND
VTGN